CAREFUSION Corp
CompletedFormerly CareFusion Corp
Spin-offSpun off from Cardinal HealthCAHNYSE
The two companies
Open either company's hub for its full SEC financials, ratios, ownership, filings, and every other event it's been part of.
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments & Apparatus
- Exchange
- —
- State of incorporation
- Record date
- August 25, 2009
- Distribution date
- August 31, 2009
- Ratio
- 0.5:1
- Parent sector
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Form
- 10-12B/A
- Filed
- July 22, 2009
Financials — parent vs spin-off
SEC XBRL · latest year- Revenue
- $222.58B
- Operating income
- $2.27B
- Net income
- $1.56B
- Total assets
- $53.12B
- Equity
- −$2.78B
- Revenue
- $968M
- Operating income
- $621M
- Net income
- $102M
- Total assets
- $9.65B
- Equity
- $5.39B
Latest reported figures from each company's own SEC filings — the parent after the separation and the spin-off as a standalone. Full multi-year history on each company hub.
Spin-off signals
score 4/8 favorable · factors, not advice- Focus-increasingYes — Industrials → Healthcare
Spin-offs into a different sector than the parent (pure-plays) have historically outperformed diversifying ones.
- Size vs parent (revenue)~0.4% of parent
Smaller spin-offs draw more forced selling from holders who can't keep them — the classic mispricing edge.
- Leverage (liabilities/assets)44%
A heavy debt load loaded onto the spin-off is a known risk; a clean balance sheet is favorable.
- Return on capital employed7.3%
EBIT ÷ capital employed — the quality metric the spin-off scorecard research weighs most.
- Operating margin64%
Profitability of the standalone business, from its own SEC filings.
- Tax-basis reportNone found
A Form 8937 (basis allocation) accompanies tax-free §355 spin-offs — favorable for taxable holders.
- Insider buying (post-spin)None recorded
Officers/directors buying their own newly independent shares (Form 4) has historically preceded outperformance.
- Time since spin-off16.8 years
Studies find the spin-off return premium concentrates in roughly the first one to three years.
Factors the spin-off research literature (Greenblatt; Cusatis-Miles-Woolridge; Desai-Jain) associates with outcomes — computed from this company's own SEC filings, shown as factors, not a recommendation. The premium is debated and not guaranteed. How we compute these ↗
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.